Key Details
Price
$0.96Annual ROE
-37.19%Beta
0.37Events Calendar
Next earnings date:
Feb 28, 2025Recent quarterly earnings:
Nov 01, 2024Recent annual earnings:
Mar 01, 2024Next ex-dividend date:
N/ARecent ex-dividend date:
N/ANext split:
N/ARecent split:
N/AAnalyst ratings
Recent major analysts updates
Market Data
Dividend
Profitability
Efficiency
Valuation
Liquidity
Cash Flow
Institutional Ownership
LEXINGTON, Mass., Nov. 08, 2024 (GLOBE NEWSWIRE) -- Rapid Micro Biosystems, Inc. (Nasdaq: RPID) (the “Company”), an innovative life sciences technology company providing mission critical automation solutions to facilitate the efficient manufacturing and fast, safe release of healthcare products, today announced that the Company will participate in the Stifel 2024 Healthcare Conference.
Rapid Micro Biosystems, Inc. (RPID) came out with a quarterly loss of $0.26 per share in line with the Zacks Consensus Estimate. This compares to loss of $0.31 per share a year ago.
LEXINGTON, Mass., Oct. 23, 2024 (GLOBE NEWSWIRE) -- Rapid Micro Biosystems, Inc. (Nasdaq: RPID) (the “Company”), an innovative life sciences technology company providing mission-critical automation solutions to facilitate the efficient manufacturing and fast, safe release of healthcare products, will release third quarter 2024 financial results prior to the market open on Friday, November 1, 2024.
LOWELL, Mass., July 17, 2024 (GLOBE NEWSWIRE) -- Rapid Micro Biosystems, Inc. (Nasdaq: RPID) (the “Company”), an innovative life sciences technology company providing mission-critical automation solutions to facilitate the efficient manufacturing and fast, safe release of healthcare products, will release second quarter 2024 financial results prior to the market open on Friday, August 2, 2024.
Rapid Micro Biosystems, Inc. (RPID) reported a quarterly loss of $0.31 per share, slightly higher than the Zacks Consensus Estimate of $0.29 per share but an improvement from the loss of $0.32 per share in the same quarter last year.
Rapid Micro Biosystems, Inc. (RPID) Q4 2023 Earnings Call Transcript
LOWELL, Mass., Feb. 20, 2024 (GLOBE NEWSWIRE) -- Rapid Micro Biosystems, Inc. (Nasdaq: RPID) (the “Company”), an innovative life sciences technology company providing mission-critical automation solutions to facilitate the efficient manufacturing and fast, safe release of healthcare products, will release fourth quarter and full year 2023 financial results prior to the market open on Friday, March 1, 2024.
LOWELL, Mass., Jan. 03, 2024 (GLOBE NEWSWIRE) -- Rapid Micro Biosystems, Inc. (Nasdaq: RPID) (the “Company”), an innovative life sciences technology company providing mission critical automation solutions to facilitate the efficient manufacturing and fast, safe release of healthcare products, today announced that the Company will participate in the 42nd Annual J.P. Morgan Healthcare Conference.
LOWELL, Mass., Nov. 07, 2023 (GLOBE NEWSWIRE) -- Rapid Micro Biosystems, Inc. (Nasdaq: RPID) (the “Company”), an innovative life sciences technology company providing mission critical automation solutions to facilitate the efficient manufacturing and fast, safe release of healthcare products, today announced that the Company will participate in the following investor conferences in New York, NY:
Rapid Micro Biosystems, Inc. (RPID) came out with a quarterly loss of $0.31 per share versus the Zacks Consensus Estimate of a loss of $0.32. This compares to loss of $0.38 per share a year ago.
FAQ
- What is the primary business of Rapid Micro Biosystems?
- What is the ticker symbol for Rapid Micro Biosystems?
- Does Rapid Micro Biosystems pay dividends?
- What sector is Rapid Micro Biosystems in?
- What industry is Rapid Micro Biosystems in?
- What country is Rapid Micro Biosystems based in?
- When did Rapid Micro Biosystems go public?
- Is Rapid Micro Biosystems in the S&P 500?
- Is Rapid Micro Biosystems in the NASDAQ 100?
- Is Rapid Micro Biosystems in the Dow Jones?
- When was Rapid Micro Biosystems's last earnings report?
- When does Rapid Micro Biosystems report earnings?
- Should I buy Rapid Micro Biosystems stock now?